Screening Subjects for HIV Vaccine Research Studies
This is a 1 time visit to determine if a subject meets the eligibility requirements for participation in an HIV vaccine study. A total of 500 subjects locally will be screened via this study. The study will consist of 1 screening visit in which subjects will have blood drawn in order to have labs processed. If it is determined the subject qualifies, then he/she will be given the chance to enroll into an HIV vaccine study (protocol HVTN 505).
• Signed informed consent document indicating that the subject (or a legally acceptable representative) has been informed of all pertinent aspects of the study.
• Subjects willing and able to comply with laboratory tests, and other study procedures.
• Age: 18-50 years of age
• Available to participate for the planned duration of the investigational vaccine study for which the screening is being done (vaccine studies may require 6 months to 18 months of clinic visits)
• Able and willing to complete the informed consent process